Latest Commercialisation News

ChemX Materials Limited has emerged from voluntary administration following a Deed of Company Arrangement, while securing a significant Japanese patent for its HiPurA® High Purity Alumina process.

Alchemy Resources has reported impressive high-grade iron ore assay results from its maiden drilling program at the Southern Ridge target in Western Australia’s Valley Bore Project, confirming substantial mineralisation from surface to depth.

Hammer Metals has initiated a targeted 1,500m reverse circulation drilling campaign at its Yandal Gold Project, focusing on extending known gold mineralisation at Orelia North and exploring new anomalies at Bronzewing South.

Carnegie Clean Energy’s Spanish subsidiary has received a significant pre-financing payment from the European Commission to advance innovations in wave energy technology through the COIN Project.

Race Oncology has raised $3.22 million through a private placement to fund its HARNESS-1 Phase 1a/b trial targeting non-small cell lung cancer, with patient enrolment expected early next year.

NH3 Clean Energy progresses its WAH2 Project through the FEED phase while forging a pivotal MoU with Japanese giant ITOCHU Corporation to develop clean ammonia bunkering in the Asia Pacific region by 2030.

Immutep has struck a strategic licensing deal with Dr. Reddy’s, granting rights to commercialise its novel cancer immunotherapy Eftilagimod Alfa across key emerging markets. The agreement includes a $20 million upfront payment and potential milestones exceeding $349 million.

State Gas Limited has raised $3.2 million through convertible notes issued at a 33% premium, alongside a $0.5 million director debt conversion, to accelerate pre-development of its Rolleston West coal seam gas project following a maiden 2P reserve certification.

Norwood Systems has successfully raised $650,000 through an oversubscribed share placement, aiming to fuel its market growth and strategic partnerships in AI-driven voice communication.

Bass Oil has signed a binding three-year gas sales agreement with Origin Energy for supply from the Vanessa Gas Project, marking a strategic entry into the East Coast Gas Market starting in 2026.

Memphasys is intensifying its direct sales efforts for the Felix™ sperm-selection device across key Middle East IVF clinics, positioning for rapid market activation upon CE Mark approval expected early 2026.

Sparc Hydrogen has appointed Alana Barlow as its inaugural CEO, marking a strategic move to accelerate commercialisation of its innovative photocatalytic water splitting technology for green hydrogen.